A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.

Clinical trial NCT00532129 · COMPLETED

Trial details

NCT number: NCT00532129
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic

Start date: 2007-11-01
Primary completion: 2012-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.